Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedA new bibliographic reference was added to the Publications section. It cites the 2025 NCCN Gastric Cancer guidelines (Ajani et al.).SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedA new PubMed-derived publication citation (about an indirect comparison of entrectinib vs. crizotinib in Asian ROS1-positive NSCLC patients) has been added to the study’s publications list. The page’s site release/version label has been updated from one revision to another.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded a publication reference: Doebele RC et al., 'Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC' (J Comp Eff Res. 2021 Dec;10(17):1271-1282) with an Erratum in 2022. The Revision has been updated from v3.5.0 to v3.5.2 to reflect the erratum.SummaryDifference0.0%

- Check38 days agoChange DetectedPadua, Veneto, Italy, 35128 was replaced with Padova, Veneto, Italy, 35128 in the locations list. Padova, Veneto, Italy, 35128 has been added to the locations.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Naples, Campania, Italy, 80131 to the locations and removed Napoli, Campania, Italy, 80131 (city name updated from Napoli to Naples).SummaryDifference0.0%

- Check67 days agoChange DetectedA new revision entry (v3.4.3, March 2026) was added and the prior revision (v3.4.2, January 2026) was removed.SummaryDifference0.1%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.